Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Lady Tata Trust Memorial
Eligibility
Inclusion criteria
Inclusion criteria: All pediatric ALL patients (=14years) getting treated under Department of pediatric oncology, Regional cancer centre, Thiruvananthapuram will be included
Exclusion criteria
Exclusion criteria: Patients/parents refusing consent for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To prospectively detect the incidence of CNS leukemia by combining CSF flow-cytometry assessment and CSF cytological assessment among children with ALL. Timepoint: 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the absolute blast cell count by CSF multicolour flow-cytometry at diagnosis and its impact on survival. 2. To assess the rapidity of clearance of CSF blasts detected by flow-cytometry during ALL therapy and its impact on survival 3. To compare the antibody expression of ALL in blood/bone marrow and CSF and its correlation with CNS involvement baseline and at relapse Timepoint: 3 years | — |
Countries
India
Contacts
Public ContactKalasekhar VS
Regional Cancer Centre, Thiruvananthapuram
Outcome results
None listed